Mind Medicine (NASDAQ:MNMD) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.60) by 6.67 percent. This is a 6.67 percent increase over losses of $(0.60) per share from the same period last year.
Broadridge Financial Solutions Reaffirmed 2024 Recurring Revenue Growth of 6%-9% YoY, Adj EPS Growth of 8%-12% YoY Vs $7.73 Est
Fiscal Year 2024 Financial Guidance
FY'24 Guidance
Updates / Changes
Recurring revenue growth constant currency
